Skip to main content
ConductScienceScienceDex
NIH funding notice RFA-AG-20-041

Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Alzheimers Disease (R21 Clinical Trial Not Allowed)

Closed on October 23, 2019.

Posted
June 26, 2019
Close date
October 23, 2019
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
2
2 new
Median first-year cost
$325,930
$651,860 in all
Institutions
2
2 contact PIs

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. UNIVERSITY OF CALIFORNIA-IRVINE1
  2. WAYNE STATE UNIVERSITY1

Most frequent study sections

  1. Special Emphasis Panel (ZRG1 MDCN-P (56))2
2 awards under RFA-AG-20-041 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2020Cell-type-specific and high-resolution profiling of postsynaptic proteomes altered in Alzheimer's disease model mice1R21AG068423-01Park, JoongkyuWAYNE STATE UNIVERSITY, MIFirst-year cost $423,500Study section ZRG1
FY2020Assessing cell specific proteomes in the presence and absence of C5a complement signaling in Alzheimer's disease models1R21AG068573-01Spitale, Robert CTenner, Andrea JoanUNIVERSITY OF CALIFORNIA-IRVINE, CAFirst-year cost $228,360Study section ZRG1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-21-0.3.10. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-AG-20-041: Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Alzheimers Disease (R21 Clinical Trial Not Allowed) | ConductScience ScienceDex